(Reuters) - A group of former Affymetrix Inc executives offered to buy the gene testing and analysis provider for about $1.5 billion, looking to derail the company's deal with Thermo Fisher Scientific ...
Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...
OXFORD, England--(BUSINESS WIRE)--Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational ...
Affymetrix adds complementary products in genetic analysis that are used in cytogenetics, genotyping and gene expression. The company’s innovative microarray platform will strengthen Thermo Fisher’s ...
Microarray giant Affymetrix http://www.affymetrix.com of Santa Clara, Calif., is raising the bar for whole-genome association studies. The first in a planned line of ...
An operator uses Affymetrix's Sigma Aligner machine for gene chip array manufacturing in Singapore. Affymetrix Inc. (Santa Clara, CA) has opened a manufacturing facility in Singapore for its GeneChip ...
the eBioscience portfolio contains comprehensive, innovative and trusted fluorochrome conjugated antibodies and reagents for immunology, oncology, and multicolor flow cytometry, as well as ...
Shares of Affymetrix jumped 19 percent Thursday after the Swiss drug firm Roche said it would pay $70 million for a license to use the Santa Clara company's DNA chips to create new ways to diagnose ...
Dec 18 (Reuters) - Affymetrix Inc , a maker of microchips used in genetic research, said it agreed to buy privately held USB Corp for about $75 million in cash, to accelerate the development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback